Cargando…
Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance
Abnormal accumulation of β-amyloid (Aβ) peptides is a culprit in Alzheimer’s disease (AD); blocking Aβ generation is therefore being explored as a logical approach for AD treatment. Here, we demonstrate that targeted inhibition of β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE-1) in...
Autores principales: | Singh, Neeraj, Das, Brati, Zhou, John, Hu, Xiangyou, Yan, Riqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299535/ https://www.ncbi.nlm.nih.gov/pubmed/35857844 http://dx.doi.org/10.1126/sciadv.abo3610 |
Ejemplares similares
-
BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1
por: Singh, Neeraj, et al.
Publicado: (2022) -
BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
por: Hu, Xiangyou, et al.
Publicado: (2018) -
BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides
por: Zhou, John, et al.
Publicado: (2023) -
BACE1 controls synaptic function through modulating release of synaptic vesicles
por: Das, Brati, et al.
Publicado: (2021) -
Role of BACE1 in Alzheimer’s synaptic function
por: Das, Brati, et al.
Publicado: (2017)